Circulating tumour cells in locally advanced breast cancer
✍ Scribed by José Ángel García-Sáenz; Miguel Martín; María Luisa Maestro; Marta Vidaurreta; Silvia Veganzones; Sara Rafael; Antonio Casado; Jana Bobokova; Javier Sastre; Virginia De la Orden; Manuel Arroyo; Eduardo Díaz-Rubio
- Book ID
- 107597539
- Publisher
- Springer Milan
- Year
- 2009
- Tongue
- Spanish
- Weight
- 157 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1699-048X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Thirty-eight patients with locally advanced breast cancer (Stage HI) were treated over a 3-year period. All patients initially received two cycles of CMF (cyclophosphamide, 100 mg/m2 p.0. dl-14; methotrexate 40mg/m2 intravenously (iv), d l and d8., 5 Fluorouracil 500 mg/m2 iv d l and d8). They were
The management of locally advanced breast cancer with single modality therapy has been associated with a high rate of systemic failure. A multimodality treatment strategy that includes induction cytotoxic chemotherapy, surgery, radiation therapy, and, possibly, hormonal ablation therapy is the curre